Benzinga | Oct 29, 2020 05:11PM EDT

Invacare: Q3 Earnings Insights

Shares of Invacare (NYSE:IVC) fell 0.8% in after-market trading after the company reported Q3 results.

Quarterly Results

Earnings per share increased 33.33% over the past year to ($0.10), which beat the estimate of ($0.18).

Revenue of $211,906,000 decreased by 10.12% year over year, which beat the estimate of $202,350,000.

Guidance

Invacare raises FY20 Sales Guidance From $810M-$840M To At Least $840M vs $826M Estimate, Adj. EBITDA From $27M-$30M to $28M-$32M

Technicals

52-week high: $11.63

52-week low: $3.90

Price action over last quarter: Up 4.51%

Company Overview

Invacare Corp makes and distributes medical equipment used in non-acute care settings. Its products are primarily sold to home medical equipment providers, residential living operators, distributors, and government health services. The firm sells products in three categories: mobility and seating, lifestyle, and respiratory therapy. Its mobility and seating products include power wheelchairs, custom manual wheelchairs, and positioning cushions. Its lifestyle products include manual wheelchairs, crutches, walkers, and homecare beds. Its respiratory products include stationary and portable oxygen concentrators and nondelivery oxygen technology. Invacare receives the largest proportion of revenue from sales in Europe.